HealthSTAT News
STAT+: RevMed’s pancreatic cancer drug nears European approval
Following a green light from the FDA, European regulators have now recommended the approval of Revolution Medicines' Rasonque for pancreatic cancer.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
Following a green light from the FDA, European regulators have now recommended the approval of Revolution Medicines' Rasonque for pancreatic cancer.
Join the argument
House rules →Comments load as you scroll.